Literature DB >> 22094298

The willingness of patients presenting with advanced glaucoma to participate in a trial comparing primary medical vs primary surgical treatment.

P Leighton1, A J Lonsdale, J Tildsley, A J King.   

Abstract

AIM: The aim of this study is to examine the attitudes of patients, who presented with advanced glaucoma in at least one eye, to participation in a randomised prospective trial comparing primary medical treatment with primary surgical treatment for advanced glaucoma.
METHODS: Patients who had presented with advanced glaucoma (>15 dB loss mean deviation on Humphrey visual field testing) in at least one eye were asked to participate. Five focus groups comprising of 4-8 patients and consisting of 29 patients in total were undertaken. The group interviews were conducted by two experienced qualitative researchers, an ophthalmic clinician was present to clarify technical issues. The focus group discussions were taped and transcribed in full, and analysed through a process of familiarisation, open (inductive) coding, theme generation, theme refinement, and thematic mapping.
RESULTS: Three overarching themes were identified: (1) the extent of patients' knowledge, (2) anxieties about surgery, and (3) concerns about compromised care due to trial involvement; these themes were further classified into eight sub-themes.
CONCLUSIONS: Patients' willingness to participate in randomised clinical studies is significantly connected to their level of comprehension and insight about the medical condition, its treatment, and the research process; misunderstandings about any of these aspects may act as a significant barrier to trial recruitment. Recruitment rates for future randomised trials may be enhanced by ensuring that patients have full and accurate information about the treatment alternatives, and that uncertainty exists for best patient outcomes between treatment options, and reassuring potential participants that the research process, in particular randomisation, will not compromise clinical care.

Entities:  

Mesh:

Year:  2011        PMID: 22094298      PMCID: PMC3272192          DOI: 10.1038/eye.2011.279

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  28 in total

1.  Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.

Authors:  K Singh; K Mehta; N M Shaikh; J C Tsai; M R Moster; D L Budenz; D S Greenfield; P P Chen; J S Cohen; G S Baerveldt; S Shaikh
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Utility values among glaucoma patients: an impact on the quality of life.

Authors:  V Gupta; G Srinivasan; S S Mei; G Gazzard; R Sihota; K S Kapoor
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

Review 3.  Medical versus surgical interventions for open angle glaucoma.

Authors:  J Burr; A Azuara-Blanco; A Avenell
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 4.  Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors.

Authors:  Edward J Mills; Dugald Seely; Beth Rachlis; Lauren Griffith; Ping Wu; Kumanan Wilson; Peter Ellis; James R Wright
Journal:  Lancet Oncol       Date:  2006-02       Impact factor: 41.316

5.  Views of glaucoma patients on provision of follow-up care; an assessment of patient preferences by conjoint analysis.

Authors:  J S Bhargava; A Bhan-Bhargava; A J E Foss; A J King
Journal:  Br J Ophthalmol       Date:  2008-07-29       Impact factor: 4.638

6.  Risk factors for rate of progression of glaucomatous visual field loss: a computer-based analysis.

Authors:  R Wilson; A M Walker; D K Dueker; R P Crick
Journal:  Arch Ophthalmol       Date:  1982-05

7.  Why do some people go blind from glaucoma?

Authors:  W M Grant; J F Burke
Journal:  Ophthalmology       Date:  1982-09       Impact factor: 12.079

8.  Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery.

Authors:  D C Broadway; I Grierson; C O'Brien; R A Hitchings
Journal:  Arch Ophthalmol       Date:  1994-11

9.  The probability of blindness from open-angle glaucoma.

Authors:  M G Hattenhauer; D H Johnson; H H Ing; D C Herman; D O Hodge; B P Yawn; L C Butterfield; D T Gray
Journal:  Ophthalmology       Date:  1998-11       Impact factor: 12.079

10.  What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies.

Authors:  Alison M McDonald; Rosemary C Knight; Marion K Campbell; Vikki A Entwistle; Adrian M Grant; Jonathan A Cook; Diana R Elbourne; David Francis; Jo Garcia; Ian Roberts; Claire Snowdon
Journal:  Trials       Date:  2006-04-07       Impact factor: 2.279

View more
  6 in total

1.  Primary trabeculectomy for advanced glaucoma: pragmatic multicentre randomised controlled trial (TAGS).

Authors:  Anthony J King; Jemma Hudson; Gordon Fernie; Ashleigh Kernohan; Augusto Azuara-Blanco; Jennifer Burr; Tara Homer; Hosein Shabaninejad; John M Sparrow; David Garway-Heath; Keith Barton; John Norrie; Alison McDonald; Luke Vale; Graeme MacLennan
Journal:  BMJ       Date:  2021-05-12

2.  Barriers and Facilitating Factors for Research Involvement in Cancer Centers: A Survey of Colorectal Cancer Center Coordinators in Germany, Austria, and Switzerland.

Authors:  Christoph Kowalski; Stefan Post; Thomas Seufferlein; Stefan R Benz; Julia Ferencz; Simone Wesselmann
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

3.  Trends in the Retinal Nerve Fiber Layer Thickness Changes with Different Degrees of Visual Field Defects.

Authors:  Wenhui Geng; Dabo Wang; Jing Han
Journal:  J Ophthalmol       Date:  2020-04-12       Impact factor: 1.909

4.  Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.

Authors:  Catherine Houghton; Maura Dowling; Pauline Meskell; Andrew Hunter; Heidi Gardner; Aislinn Conway; Shaun Treweek; Katy Sutcliffe; Jane Noyes; Declan Devane; Jane R Nicholas; Linda M Biesty
Journal:  Cochrane Database Syst Rev       Date:  2020-10-07

5.  Structural Change Can Be Detected in Advanced-Glaucoma Eyes.

Authors:  Akram Belghith; Felipe A Medeiros; Christopher Bowd; Jeffrey M Liebmann; Christopher A Girkin; Robert N Weinreb; Linda M Zangwill
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

6.  Factors influencing the enrollment in randomized controlled trials in orthopedics.

Authors:  Christopher T Lim; Heather J Roberts; Jamie E Collins; Elena Losina; Jeffrey N Katz
Journal:  Contemp Clin Trials Commun       Date:  2017-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.